Page 1

▪ Net sales of € 6,158m in the third quarter , up + 3.8 % on a like - for - like ( LFL ) basis , and + 5.8 % on a reported basis ▪ Another quarter focused on execution and delivery : o All categories contributing to growth with sustained strong momentum in EDP , continued recovery in Specialized Nutrition and Waters o Higher inflation and supply chain pressure , greater focus on productivity and pricing initiatives o Local First implementation on track ▪ 2021 guidance reiterated : return to profitable growth in H2 , and FY recurring operating margin broadly in line with 2020 Capital market event to take place on March 8th , 2022 Juergen Esser : Chief Financial Officer statement " Today's results further underscore our progress to profitable growth . Our actions and focused delivery across all parts of the company ensured that all categories contributed to a solid performance this quarter . Another quarter focused on execution and delivery 2021 guidance reiterated We see clear evidence of our brands ' strengths and relevance to the global health and wellness agenda . Our Essential Dairy and Plant - based business continued its strong momentum , particularly in Europe and North America , with market share gains on key platforms . Our Waters business , led by a strong performance in Europe , benefited from the improved out of home mobility . And our Specialized Nutrition business also saw good dynamics driven by Adult Nutrition and the return to growth of Infant Milk Formula in China . I. 2021 THIRD - QUARTER SALES € million except % Like just about everyone across the sector and beyond , we see inflationary pressures across the board . What started as increased inflation on material costs evolved into widespread constraints impacting our supply chain in many parts of the world . That said , we are putting even greater focus on productivity and pricing actions to mitigate the impact on our performance , thus re - iterating our FY 2021 guidance . " BY REPORTING ENTITY EDP Specialized Nutrition Waters BY GEOGRAPHICAL AREA Europe & Noram¹ Rest of the World Q3 2020 DANONE ONE PLANET , ONE HEALTH 3,108 3,269 + 5.2 % 1,698 1,777 + 4.6 % 1,015 1,112 + 9.6 % Q3 Reported LFL Sales 2021 change Growth 3,334 3,498 2,486 2,660 TOTAL 5,821 ¹North America ( Noram ) : United States and Canada 6,158 2021 Third - Quarter Sales Press release - Paris , October 19 , 2021 + 4.9 % + 7.0 % + 5.8 % + 4.1 % + 2.9 % + 4.6 % + 3.9 % + 3.7 % 9M Growth 2020 9M 2021 9,686 + 0.6 % 9,699 -5.3 % 5,441 5,294 + 2.4 % 2,864 3,031 + 3.8 % -0.8 % 18,004 18,011 Reported LFL Sales Volume change Growth Growth + 0.6 % 10,156 10,282 + 1.2 % -2.1 % 7,848 7,729 -1.5 % For more information , please contact : Media Relations : +33 1 44 70 11 89 - Investor Relations : +33 1 44 35 20 76 Danone : 17 , Boulevard Haussmann , 75009 Paris , France -0.1 % -2.7 % + 5.8 % + 0.0 % + 3.5 % -0.8 % + 4.5 % + 1.1 % -4.6 % -0.6 % + 2.5 % + 0.7 % + 2.2 % -2.1 % + 2.3 % -0.9 % -1